| Literature DB >> 14996597 |
Pedro A Lemos1, Chourmouzios A Arampatzis, Francesco Saia, Angela Hoye, Muzaffer Degertekin, Kengo Tanabe, Chi-Hang Lee, Paul Cummins, Pieter C Smits, Eugène McFadden, Georgios Sianos, Pim de Feyter, Willem J van der Giessen, Ron T van Domburg, Patrick W Serruys.
Abstract
A total of 91 patients with 112 lesions received 2.25-mm sirolimus-eluting stents (SESs), and these lesions were compared with those treated with SESs of > or =2.5-mm diameter in the same procedure (n = 109). The reference diameters were 1.88 +/- 0.34 and 2.52 +/- 0.57 mm, respectively (p <0.01). At follow-up, the late lumen loss was 0.07 +/- 0.48 mm for the 2.25-mm SES versus 0.03 +/- 0.38 mm for the larger SES (p = 0.5), and the binary restenosis rate was 10.7% versus 3.9%, respectively (p = 0.1). The 12-month target lesion revascularization rate was 5.5%. In conclusion, 2.25-mm SESs were associated with low rates of clinical and angiographic late complications.Entities:
Mesh：
Substances：
Year: 2004 PMID： 14996597 DOI： 10.1016/j.amjcard.2003.11.037
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778